Skip to content
healthcare.dev

XURIDEN

NDC 50633-330, uridine triacetate, granule, from BTG International Inc.

Product NDC
50633-330
Status
Listed
Labeler
BTG International Inc
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208169
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50633-330 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • URIDINE TRIACETATE951 mg/g

Pharmacologic classes

Analogs/Derivatives [Chemical/Ingredient]; Pyrimidine Analog [EPC]; Pyrimidines [Chemical/Ingredient]

Package NDCNDC-11Package
50633-330-305063303303030 PACKET in 1 CARTON (50633-330-30) / 2 g in 1 PACKET (50633-330-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/88ca4d2b-3905-474b-9fd6-c81474f2fb4b

Use it

Look up 50633-330 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50633-330 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50633-330. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.